BA
UPI

Bard Associates’s UROPLASTY INC-NEW UPI Stock Holding History

Bard Associates’s Portfolio UPI Stock Details UPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-300,331
Closed -$366K – 176
2015
Q1 		$366K Sell
300,331
-3,500
-1% -$4.71K 0.18% 121
2014
Q4 		$626K Hold
303,831
– – 0.29% 100
2014
Q3 		$760K Sell
303,831
-2,741
-0.9% -$7.15K 0.36% 91
2014
Q2 		$822K Sell
306,572
-4,400
-1% -$13.8K 0.33% 106
2014
Q1 		$1.13M Sell
310,972
-1,700
-0.5% -$6.64K 0.48% 84
2013
Q4 		$880K Sell
312,672
-6,150
-2% -$18.7K 0.37% 95
2013
Q3 		$1.05M Sell
318,822
-6,200
-2% -$17.3K 0.47% 80
2013
Q2 		$673K Buy
+325,022
New +$745K 0.31% 110

Bard Associates's UPI Position: Q2 2015 in Review

Bard Associates sold out of UROPLASTY INC-NEW (UPI) in Q2 2015, closing a stake of 300,331 shares — an estimated $366K sold.

Bard Associates first reported a position in UPI in Q2 2013 and held it in 8 quarters. The position peaked at $1.13M in Q1 2014. 0 funds tracked by Wall St. Rank hold UPI as of Q2 2015.

  • Bard Associates reported no remaining UROPLASTY INC-NEW position as of Q2 2015 after selling out during the quarter.
  • Bard Associates sold 300,331 UROPLASTY INC-NEW shares in Q2 2015, an estimated $366K.
  • Bard Associates first reported a position in UROPLASTY INC-NEW in Q2 2013 and held it in 8 quarters.
  • Bard Associates's UROPLASTY INC-NEW position peaked at $1.13M in Q1 2014.
  • 0 funds tracked by Wall St. Rank held UROPLASTY INC-NEW as of Q2 2015.

Based on Bard Associates's 13F filing for Q2 2015, filed 14 Aug 2015.